Fukuma N, Hoy T, Phillips D I, McLachlan S M
Department of Medicine, University of Wales, College of Medicine, Heath Park, Cardiff.
Thyroid. 1992 Winter;2(4):291-7. doi: 10.1089/thy.1992.2.291.
Immunoglobulin molecules on the surface of a B lymphocyte are the endogenous "receptors" to which specific antigens bind. Studies in mice have shown that a monoclonal antibody, conjugated with palmitate to provide a lipid tail, can be inserted into the cell membrane to provide a "surrogate" antigen receptor. We have investigated whether a palmitate conjugate of a human monoclonal antibody specific for thyroglobulin (TG) could function as a surrogate TG receptor on blood mononuclear cells separated into fractions enriched for T cells or depleted of T cells (non-T cells). Using flow cytometry, we detected surrogate TG receptors on non-T (but not on T) cells from 11 of 11 individuals studied (5 Hashimoto patients and 6 control donors). In contrast, endogenous TG receptors could only be detected on non-T cells from 1 of 3 Hashimoto patients and from 0 of 4 control donors. Because of the efficient binding of TG by surrogate receptors on non-T cells, we assessed the ability of such cells to present TG to T cells. Proliferation in response to TG was observed in T cells from only 1 of 5 Hashimoto patients. This low frequency of response was no different from that previously detected using cultures of T cells and autologous dendritic cells. Therefore, the successful generation of surrogate receptors on non-T cells is not associated with more efficient TG presentation of T cells. Furthermore, the significance of the present study is that the T cells, not the antigen-presenting cells, are likely to be the limiting element in the T cell proliferative response to TG and other thyroid autoantigens.
B淋巴细胞表面的免疫球蛋白分子是特异性抗原结合的内源性“受体”。对小鼠的研究表明,与棕榈酸酯偶联以提供脂质尾的单克隆抗体可插入细胞膜以提供“替代”抗原受体。我们研究了对甲状腺球蛋白(TG)具有特异性的人单克隆抗体的棕榈酸酯偶联物是否可作为分离为富含T细胞或T细胞耗竭(非T细胞)部分的血液单核细胞上的替代TG受体。使用流式细胞术,我们在11名研究对象(5名桥本患者和6名对照供体)的非T细胞(而非T细胞)上检测到了替代TG受体。相比之下,仅在3名桥本患者中的1名以及4名对照供体中的0名的非T细胞上检测到了内源性TG受体。由于非T细胞上的替代受体对TG具有高效结合能力,我们评估了此类细胞将TG呈递给T细胞的能力。仅在5名桥本患者中的1名的T细胞中观察到了对TG的增殖反应。这种低反应频率与先前使用T细胞和自体树突状细胞培养物检测到的频率没有差异。因此,非T细胞上替代受体的成功产生与T细胞更有效的TG呈递无关。此外,本研究的意义在于,在对TG和其他甲状腺自身抗原的T细胞增殖反应中,T细胞而非抗原呈递细胞可能是限制因素。